NGAL (also known as Lipocalin-2 or Neutrophil Gelatinase-associated Lipocalin) is a small, ~25kDa secreted protein expressed in epithelial tissues throughout the body.
Elevation of neutrophil gelatinase-associated lipocalin (NGAL) in non-azotemic dogs with urinary tract infection: E. Daure, et al.; Res. Vet. Sci. 950, 1181 (2013), Abstract;
Evaluation of serum neutrophil gelatinase-associated lipocalin (NGAL) activity in dogs with chronic kidney disease: H.J. Ahn, et al.; Vet. Rec. 173, 452 (2013), Abstract;
Evaluation of urinary catheters coated with sustained-release varnish of chlorhexidine in mitigating biofilm formation on urinary catheters in dogs: G. Segev, et al.; J. Vet. Intern. Med. 27, 39 (2013), Abstract;
Neutrophil gelatinase-associated lipocalin, a sensitive urinary biomarker of acute kidney injury in dogs receiving gentamicin: K. Kai, et al.; J. Toxicol. Sci. 38, 269 (2013), Abstract;
Serum and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) COncentration in Healthy Dogs, Dogs with Chronic Kidney Disease and Dogs with Sepsis: A. Cobrin; (2013), (dissertation), Full Text
Urinary biomarkers of renal disease in dogs with X-linked hereditary nephropathy: M.B. Nabity, et al.; J. Vet. Intern. Med. 26, 282 (2012), Abstract;
General Literature References
Application of emerging biomarkers of acute kidney injury in development of kidney-sparing polypeptide-based antibiotics: D. Burt, et al.; Drug Chem. Toxicol. 37, 204 (2014), Abstract;
Ultra sensitive (1.279 pg/ml) ELISA kit, enabling reduced input sample and matrix interference, for the quantification of KIM-1, an early biomarker for kidney injury or disease.